Skip to main content
05/04/2023

Dr. Simo Schwartz Jr. has been selected as a member of the European Medicines Agency's Nanomedicine Expert Working Group

El Dr. Simó Schwartz Jr. 

El Dr. Simó Schwartz Jr. 

05/04/2023

The researcher and strategic director of the Biobank and Biomodel at Vall d'Hebron Barcelona Campus Hospital will help create guidelines to regulate the development of new therapies and technologies in this area.

Dr. Simo Schwartz Jr, principal investigator of the Pharmacological Targeting and Release group at Vall d'Hebron Research Institute (VHIR) and strategic director of the Biobank and Biomodel at Vall d'Hebron Barcelona Campus Hospital, has been selected as a member of one of the European Medicines Agency (EMA) Operational Expert Groups. Specifically, the group of experts that assists the Working Group on New Therapies and Technologies in Nanomedicines of the EMA (NTWP Operational Expert Group on nanomedicines).

The objective of this advisory committee is to support the development of guidelines to technically and legally regulate the creation of new therapies and technologies in the area of nanomedicine. The group is currently working on the development of a guideline on the treatment and development of nanomedicines with non-biodegradable parts. Dr. Schwartz Jr. is a leading international scientist in this field with extensive professional experience in the sector. He currently serves as president of the European Association of Nanomedicine.

Related news

The team was born from the union of the Clinical Biochemistry and the Drug Delivery and Targeting groups with the aim of improving the diagnostic and prognostic process and developing new therapeutic strategies.

Vall d’Hebron ha celebrat avui la Jornada del Dia Mundial contra el Càncer, una malaltia cada cop més freqüent que patiran al llarg de la vida un de cada dos homes i una de cada tres dones del nostre entorn.

The members visited the facilities of the ICU of the General Hospital, the Clinical Laboratories and the Research Unit for Molecular Therapy (UITM).

Related professionals

Simon Schwartz Navarro

Simon Schwartz Navarro

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Guillem Pintos Morell

Guillem Pintos Morell

Postdoctoral researcher
Drug Delivery and Targeting
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.